Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_assertion type Assertion NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_head.
- NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_assertion description "[Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_provenance.
- NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_assertion evidence source_evidence_literature NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_provenance.
- NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_assertion SIO_000772 19392865 NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_provenance.
- NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_assertion wasDerivedFrom befree-20140225 NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_provenance.
- NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_assertion wasGeneratedBy ECO_0000203 NP468083.RAn2nsJ1KOsnaVsiNnu0yXc5eaGgw_0hVb6qo89Vigy9A130_provenance.